Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: tonyt who wrote (23428)	7/22/1998 11:07:00 AM
From: Machaon	Read Replies (1) \| Respond to of 32384

<< yeah, whatever you say ;-) >> Brilliant response! What do think about Ligand's "off-label" corporate plan? I think that it is brilliant. They are taking drugs like Targretin and Panretin, which have many different disease applications, and trying to get FDA approval for small "fast track" markets! Once approved, the revenue will fund larger clinical trials for diseases of larger populations. But, the new trials won't have to include Phase I testing, and will probably go thru Phase II/III testing. And, if results come out of the trials, the medicines can be made available "off-label" due to the new FDA rules. It shows that Ligand really has it's "clinical" business plan together. Now, all it's going to take is good execution! "Thoughtful planning and careful risk management and execution by the Ligand team have accelerated Ligand toward commercialization and achievement of our goals to have the first Ligand product on the market in 1998 and to achieve profitability in the 1999 timeframe" "With four products in pivotal trials we believe Ligand's probability of achieving commercially successful medicines in the near future is good." That's David E. Robinson's comments in the 1997 annual report. It's now "five" products, two of which are before the FDA. There's a lot riding on Panretin and Targretin. They must be successful in order for LGND to be a worthwhile investment. So far, both drugs have shown significant efficacy in clinical trials. I'm sure you will join with us as we do the GO LGND cheer! Give me an L Give me an I Give me an G Give me an A Give me an N Give me an D What does it spell? Hmmmmm!? Sorry Tony, I'll give you a few minutes to figure it out. <g>